EP 2903992 A1 20150812 - 7-AZAINDOLE-2,7-NAPHTHYRIDINE DERIVATIVE FOR THE TREATMENT OF TUMORS
Title (en)
7-AZAINDOLE-2,7-NAPHTHYRIDINE DERIVATIVE FOR THE TREATMENT OF TUMORS
Title (de)
7-AZAINDOL-2,7-NAPHTHYRIDIN-DERIVAT ZUR BEHANDLUNG VON TUMOREN
Title (fr)
DÉRIVÉ 7-AZAINDOLE-2,7-NAPHTHYRIDINE POUR LE TRAITEMENT DE TUMEURS
Publication
Application
Priority
- DE 102012019369 A 20121002
- EP 2013002696 W 20130909
Abstract (en)
[origin: CA2886886A1] The invention relates to the compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridino-3-yl)- [2,7]naphthyridino-1-ylamine and its pharmaceutically usable salts and/or tautomers. The invention also relates to the use of said compounds for the treatment of tumors, tumor growth, tumor metastases and/or AIDS.
IPC 8 full level
C07D 519/00 (2006.01); A61K 31/4375 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/4375 (2013.01 - EP US); A61K 45/06 (2013.01 - US); A61P 31/18 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); C07D 471/04 (2013.01 - EP US); C07D 519/00 (2013.01 - EP US)
Citation (search report)
See references of WO 2014053208A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DE 102012019369 A1 20140403; AR 092772 A1 20150429; AU 2013327282 A1 20150514; CA 2886886 A1 20140410; CN 104736543 A 20150624; EP 2903992 A1 20150812; IL 237976 A0 20150531; JP 2015531381 A 20151102; US 2015252041 A1 20150910; US 9382244 B2 20160705; WO 2014053208 A1 20140410
DOCDB simple family (application)
DE 102012019369 A 20121002; AR P130103564 A 20131002; AU 2013327282 A 20130909; CA 2886886 A 20130909; CN 201380051232 A 20130909; EP 13759449 A 20130909; EP 2013002696 W 20130909; IL 23797615 A 20150326; JP 2015534920 A 20130909; US 201314432767 A 20130909